BRIEF-Nicox and Bausch & Lomb announce FDA acceptance of new drug application for Vesneo
Sept 22 (Reuters) - Nicox SA :
* Bausch & Lomb and Nicox announce FDA acceptance of new drug application for novel glaucoma candidate Vesneo (latanoprostene bunod)
* FDA has set an action date of July 21, 2016 to complete its review, as per the Prescription Drug User Fee Act (PDUFA)
Source text for Eikon: Further company coverage: (Gdynia Newsroom)
© Thomson Reuters 2017 All rights reserved.